Menu
EFFECT OF SUBCUTANEOUS CASIRIVIMAB AND IMDEVIMAB ANTIBODY COMBINATION VS PLACEBO ON DEVELOPMENT OF SYMPTOMATIC COVID-19 IN EARLY ASYMPTOMATIC SARS-COV-2 INFECTION. A RANDOMIZED CLINICAL TRIAL In this...
Read More >>No posts found!